A5067779491- Pleural and Pulmonary Diseases
- Antifungal resistance and susceptibility
- Medical Imaging and Pathology Studies
- Fungal Infections and Studies
- Mechanical Circulatory Support Devices
- Lung Cancer Diagnosis and Treatment
- Respiratory Support and Mechanisms
- Trauma Management and Diagnosis
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Infectious Diseases and Tuberculosis
- COVID-19 Clinical Research Studies
- Tuberculosis Research and Epidemiology
- Venous Thromboembolism Diagnosis and Management
- Long-Term Effects of COVID-19
- Intensive Care Unit Cognitive Disorders
- Pneumothorax, Barotrauma, Emphysema
- Tracheal and airway disorders
- Myasthenia Gravis and Thymoma
- Pneumocystis jirovecii pneumonia detection and treatment
- Infectious Diseases and Mycology
- Lymphatic Disorders and Treatments
- Amoebic Infections and Treatments
- Sarcoidosis and Beryllium Toxicity Research
- Cardiac Arrest and Resuscitation
- Head and Neck Anomalies
Westchester Medical Center
2016-2025
New York Medical College
2016-2024
Pulmonary and Critical Care Associates
2017-2021
Health Net
2020-2021
SleepMed
2017-2021
Elmhurst Hospital Center
2013-2018
Jacobi Medical Center
2018
Temple University Hospital
2018
Icahn School of Medicine at Mount Sinai
2013-2016
Mount Sinai Queens
2015
Section:ChooseTop of pageAbstract <<ContentsOverviewSummary Recommendation...MethodsRecommendations for Speci...ConclusionsReferencesCITING ARTICLES
The epidemiology and mycology of invasive candidiasis in the ICU is well-described certain types critically ill patients but not others. One population that has been scarcely studied non-neutropenic admitted specifically to medical ICUs. Even less known about broader category without active oncological disease. This group constitutes a very large share requiring critical care across globe, especially era SARS-CoV-2 pandemic. We analysed candidaemia episodes occurred non-oncological our...
Corticosteroid dosing in the range of 0.5-2 mg/kg/day methylprednisolone equivalents has become a standard part management intensive care unit (ICU) patients with COVID-19 pneumonia based on positive results randomized trials and meta-analysis. Alongside such conventional dosing, administration 1 gm daily (pulse dosing) also been reported literature claims favorable outcomes. Comparisons between disparate approaches to corticosteroids for Coronavirus disease 2019 (COVID-19) are lacking. In...
Background: The incidence of invasive fungal infections is increasing in immune-competent and immune-compromised patients. An examination the recent literature related to treatment was performed address two clinical questions. First, patients with proven or probable pulmonary aspergillosis, should combination therapy a mold-active triazole plus echinocandin be administered vs. monotherapy? Second, critically ill at risk for candidiasis who are non-neutropenic not transplant recipients,...
Objectives: The characteristics of patients with Acute Respiratory Distress Syndrome (ARDS) as a complication Babesia microti infection have not been systematically described.Methods: Adult admitted to the medical intensive care unit (MICU) tertiary hospital in Lower Hudson Valley New York from 1/1/2008 8/1/2016 were evaluated for ARDS complicating babesiosis.Results: Of 22 babesiosis MICU, eight (36.4%; 95% CI: 19.7–57.0%) had ARDS. Six (75%) developed following initiation anti-babesia drug...
Klebsiella pneumoniae is an increasingly recognized cause of a unique invasive syndrome manifesting as pyogenic liver abscess and hematogenous extrahepatic dissemination to variety sites, including the lung. Originally described only in Asia, this entity has now been reported across continents ethnicities. Intrathoracic complications (IKPLAS) have characterized sporadically but not subject all-encompassing investigation. Review English-language literature yields no reports acute respiratory...